Friday, March 29, 2024

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

COVID Shot Transmits Aerosolized Antibodies to Those Who’ve Not Gotten It: Study

people facing each other

A peer reviewed study recently published in Immunohorizons has provided evidence that individuals, who received messenger RNA (mRNA) COVID-19 shots, are able to transmit aerosolized antibodies to unvaccinated individuals. The study, which was originally reported in preprint in May 2022, looked at masks worn for one day by laboratory workers who received a COVID shot. […]

Novel mRNA Lyme Shots Could Be Released in 2025

test tube and tick

Two novel messenger RNA (mRNA) shots for Lyme disease currently in late-stage clinical trials could hit the market as early as 2025, Moderna announced earlier this year. Also in the race to develop the first-ever mRNA product to prevent Lyme disease are Pfizer and Austria-based Valneva, which entered into a collaborative agreement in April 2020 […]

The Threat of Self-Spreading Vaccines

doctor and DNA

It may sound like the plot of a science fiction movie, but U.S. National Institutes of Health (NIH) funded scientists have been secretly working on genetically-engineered live virus vaccines, which they refer to as “contagious” vaccines, that can transmit vaccine strain viruses through a population on their own. The vaccines are so contagious that only […]

Another Shot at a Vaccine for Lyme Disease

holding up a tick

The U.S. National Institutes of Health (NIH) has provided the University of Maryland with a $3.5 million dollar grant to develop a vaccine for Lyme disease.1 Principal investigators Utal Pal, PhD, professor at the Virginia-Maryland College of Veterinary Medicine at the University of Maryland College of Agriculture and Natural Resources and Matthias Schnell, PhD, director […]

Lyme Disease Vaccines: Past and Future

tick on sleeve

Story Highlights A new Lyme disease vaccine candidate approved by the FDA using the fast track process is currently in its second phase of clinical trials. In 1998, the FDA granted licensure for a Lyme disease vaccine called LYMErix. Following reports of severe adverse reactions to LYMErix, GlaxoSmithKline (formerly SmithKline Beecham) withdrew the vaccine from […]

Search in Site

To search in site, type your keyword and hit enter

Search